Compare FULC & GCBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FULC | GCBC |
|---|---|---|
| Founded | 2015 | 1889 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 467.8M | 391.8M |
| IPO Year | 2019 | 1998 |
| Metric | FULC | GCBC |
|---|---|---|
| Price | $6.98 | $24.02 |
| Analyst Decision | Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $16.38 | N/A |
| AVG Volume (30 Days) | ★ 677.6K | 8.3K |
| Earning Date | 04-27-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 1.66% |
| EPS Growth | N/A | ★ 26.21 |
| EPS | N/A | ★ 1.13 |
| Revenue | N/A | ★ $4,117,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $21.11 |
| Revenue Growth | N/A | ★ 11.06 |
| 52 Week Low | $5.47 | $21.16 |
| 52 Week High | $15.74 | $26.04 |
| Indicator | FULC | GCBC |
|---|---|---|
| Relative Strength Index (RSI) | 40.99 | 55.72 |
| Support Level | $6.39 | $22.74 |
| Resistance Level | $7.09 | $24.78 |
| Average True Range (ATR) | 0.47 | 0.54 |
| MACD | -0.06 | 0.00 |
| Stochastic Oscillator | 10.81 | 66.67 |
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing small molecules for genetically defined rare diseases. Its product candidate, Pociredir, is an oral small molecule designed to induce fetal hemoglobin (HbF) and is in clinical development for sickle cell disease (SCD). The company completed dosing in the Phase 1b PIONEER trial evaluating pociredir in adults with SCD and reported clinical data showing clinically relevant HbF induction and improvements in markers of hemolysis and anemia. The company has also generated a pipeline of clinical-stage and pre-clinical programs targeting the root causes of rare genetic diseases.
Greene County Bancorp Inc is a holding firm. Its primary business involves overseeing and directing the business of The Bank of Greene County and monitoring its cash position. Through its directly and indirectly owned subsidiaries, the company engages in attracting retail deposits, along with funds generated from operations and borrowings, predominantly in one to four-family residential mortgage loans, commercial real estate mortgage loans, consumer loans, home equity loans, and commercial business loans. It also serves local municipalities' banking needs and operates a real estate investment trust.